DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Adobe CFO Dan Durn to depart company in June 2026
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Lake Street Capital Markets Downgrades DermTech Inc. (DMTK) to Hold
April 19, 2024 7:29 AM EDTLake Street Capital Markets analyst Thomas Flaten downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Hold with a price target of $0.63.
For an analyst ratings summary and ratings history on DermTech Inc. click here. For more ratings news on DermTech Inc. click here.
Shares of DermTech Inc. closed at $0.59 yesterday.
... MoreBTIG Downgrades DermTech Inc. (DMTK) to Neutral
April 19, 2024 6:03 AM EDTBTIG analyst Sung Ji Nam downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Neutral.
The analyst comments "After the market close, DermTech announced that it has initiated a formal strategic review process. DMTK will consider all strategic options, including an acquisition, merger, reverse merger, business combination, licensing, sale of assets, or other transaction. In addition, DMTK announced it is again reducing its workforce, this time by 56%, or by ~100 employees. We spoke to the company following its... More
